Csenge Advisory Group’s LeMaitre Vascular LMAT Stock Holding History

Csenge Advisory Group’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-5	Closed	–	–	891
2018 Q3	$0	Buy	+5	New	+$180	﹤0.01%	1339

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

TAM

THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

SCA

Summit Creek Advisors Minneapolis, Minnesota $487M AUM 11.23% 1-Year Est. Return

Csenge Advisory Group's LMAT Position: Q4 2018 in Review

Csenge Advisory Group sold out of LeMaitre Vascular (LMAT) in Q4 2018, closing a stake of 5 shares.

Csenge Advisory Group first reported a position in LMAT in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 139 funds tracked by Wall St. Rank hold LMAT as of Q4 2018.

Csenge Advisory Group reported no remaining LeMaitre Vascular position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 5 LeMaitre Vascular shares in Q4 2018.
Csenge Advisory Group first reported a position in LeMaitre Vascular in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's LeMaitre Vascular position peaked at $0 in Q3 2018.
139 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.